LAGUNA HILLS, Calif., March 29, 2016 -- Sonendo®, Inc., the developer of a disruptive technology for the endodontic marketplace, announces their attendance at this year’s American Association of Endodontists (AAE) annual meeting in San Francisco.
On Wednesday, April 6th, at 10:45 a.m. PDT in the main exhibit hall, Prashanthi Vandrangi, PhD, MS and Tyler Baker, DDS, MS will be sharing the latest research and clinical results on the GentleWave® System, including biofilm, and bacteria removal and improved patient outcomes. About the presentation Dr. Vandrangi stated, “It is remarkable to see just how much progress we have made in improving patient outcomes by challenging conventional thinking in root canal therapy and leveraging advancements in technology.”
On Thursday, April 7th, at 4:30 p.m. PDT, Dr. Joe Maggio, DDS past president of the AAE, will deliver a presentation titled, Beyond Conventional Canal Disinfection, which will showcase advancements in clinical efficacy achieved with the GentleWave System. Regarding the presentation Dr. Maggio stated, “Only endodontists who are forward-thinking enough to think they can change endodontics are the ones who actually will. This presentation points the way to the future.”
Results achieved by the GentleWave System will be included in eight session and oral poster presentations. In addition, Sonendo will exhibit the GentleWave System at the 2016 AAE annual meeting from April 6 to April 9, at the Moscone Convention Center, Booth # 317.
About Sonendo®
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave® System, available in the US, shows significant improvements in clinical efficacy, and treatment efficiency when compared to conventional root canal techniques1-2. For more information please visit: www.sonendo.com.
1Molina B et al. (2015) J Endod. 41:1701-05. 2Haapasalo M et al. (2014) J Endod. 40:1178-81.
Forward-Looking Statements
This announcement contains forward-looking statements that are based on management's beliefs, assumptions and expectations and on information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
Media Contact: Bob Guyatt Vice President of Marketing 949.766.3636


Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 



